Evaluation of surrogate matrices for standard curve preparation in tissue bioanalysis

Bioanalysis

Volumn 4, Issue 21, 2012, Pages 2579-2587

  Chen, Susan ^a   Wu, Jing Tao ^a   Huang, Ron ^a,b  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEPRIDIL; BROMOPRIDE; BUPIVACAINE; CHLORPROMAZINE; CLOZAPINE; DISOPYRAMIDE; METOCLOPRAMIDE; TERFENADINE;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; DILUTION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; EVALUATION; FEASIBILITY STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRECIPITATION; PROCESS MODEL; QUANTITATIVE ANALYSIS; SAMPLING; STANDARD; STRUCTURE ACTIVITY RELATION; TISSUE BIOANALYSIS; TISSUE STRUCTURE; TISSUE SURROGATE MATRIX;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MICE; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 84870160410     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.237     Document Type: Article

References (11)

1. ICH: Guideline for Industry. Pharmacokinetics: Guidance for repeated dose tissue distribution studies. Federal Register 60(40), 11274-11275 (1995).
2. Yu C, Cohen L. Tissue sample preparation: not the same old grind. LC GC 21, 1038-1048 (2003).
3. Drummer OH. Requirements for bioanalytical procedures in postmortem toxicology. Anal. Bioanal. Chem. 388(7), 1495-1503 (2007). (Pubitemid 47150875)
4. Blasco C, Di Corcia A, Pico Y. Determination of tetracyclines in multi-species animal tissues by pressurized liquid extraction and liquid chromatography-tandem mass spectrometry. Food Chem. 116(4), 1005-1012 (2009).
5. Lu Y, Zheng T, Dai Z et al. Rapid determination of chloramphenicol in soft-shelled turtle tissues using online MSPD-HPLC-MS/MS. Food Chem. 134(1), 533-539 (2012).
6. US Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation, Rockville, MD, USA (2001).
7. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays. AAPS J. 9(1), E30-E42 (2007). (Pubitemid 46296546)
8. Zhou M. Regulated Bioanalytical Laboratories: Technical and Regulatory Aspects from Global Perspectives. John Wiley and Sons, 23 (2011).
9. Smith KM, Xu Y. Tissue sample preparation in bioanalytical assays. Bioanalysis 4(6), 741-749 (2012).
10. Barroso M, King K, Zhang X et al. Case studies of accurate measurement of small molecule drugs in various tissues: knowledge versus assumption. Presented at: ASMS Annual Conference. CO, USA, 1-5 June 2008
11. Lipinski CA, Lombardo F, Dominy BF, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 463-26 (2001).